India Digest: Biocon Biologics, RMZ Corp in talks to raise funding

Biocon Ltd, a biopharmaceutical company headquartered in Bengaluru, is set to raise $30 million for its biosimilar unit from a private equity fund managed by Tata Capital Ltd. In a separate development, Canada-based Brookfield Asset Management has initiated talks with Bengaluru-based developer RMZ Corp to acquire a part of its office projects, per a report by VC Circle.